InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Schall Thomas J., 董事长兼首席执行官. Director active across 2 companies, notably ChemoCentryx, Inc.. In total, 8 filings have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €201k. Activity tracked since 1 December 2021. The latest transaction was filed on 15 January 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Schall Thomas J. is Président-Directeur Général. He has 8 filings in total, and across the recent filings available, the transactions are acquisitions, with EUR 201060 of buys and EUR 0 of sells between 2021-12-03 and 2026-01-20. His listed companies are Immuneering Corp, where he is Director, and ChemoCentryx, Inc., where he is President and CEO.